Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) EBT Margin (2016)

Rocket Pharmaceuticals' EBT Margin history spans 2 years, with the latest figure at 1368.11% for Q3 2018.

  • For Q3 2018, EBT Margin changed N/A year-over-year to 1368.11%; the TTM value through Jun 2019 reached 9751.19%, changed N/A, while the annual FY2015 figure was 1750.98%, 86485.0% up from the prior year.
  • EBT Margin for Q3 2018 was 1368.11% at Rocket Pharmaceuticals, down from 4248.95% in the prior quarter.
  • Across five years, EBT Margin topped out at 4917.22% in Q1 2016 and bottomed at 1368.11% in Q3 2018.